Correlation Between Reviva Pharmaceuticals and Innate Pharma

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Innate Pharma, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Innate Pharma.

Diversification Opportunities for Reviva Pharmaceuticals and Innate Pharma

-0.41

Correlation Coefficient

Reviva Pharmaceuticals  Innate Pharma

Very good diversification

The 3 months correlation between Reviva and Innate is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Innate Pharma go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Innate Pharma

Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to under-perform the Innate Pharma. In addition to that, Reviva Pharmaceuticals is 1.07 times more volatile than Innate Pharma. It trades about -0.13 of its total potential returns per unit of risk. Innate Pharma is currently generating about 0.03 per unit of volatility. If you would invest  195.00  in Innate Pharma on December 28, 2024 and sell it today you would earn a total of  2.00  from holding Innate Pharma or generate 1.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Innate Pharma

Reviva Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Reviva Pharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Innate Pharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical indicators, Innate Pharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Reviva Pharmaceuticals and Innate Pharma

The main advantage of trading using opposite Reviva Pharmaceuticals and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.

The idea behind Reviva Pharmaceuticals Holdings and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.